Fig. 3
From: ANGPTL4 suppresses progression and improves cisplatin sensitivity in cervical cancer
ANGPTL4 enhances sensitivity of CC cells to cisplatin treatment. The viability of ANGPTL4-overexpressing cells was determined using MTS assay after cisplatin treatment for 24 and 48 h in (a) SiHa and (b) CaSki cells (OE_ANG vs. OE_C). The viability of ANGPTL4-knockdown cells was assessed following cisplatin exposure for 24 and 48 h in (c) SiHa and (d) CaSki cells (KD_ANG vs. KD_C). Cell viability was expressed as a percentage relative to the untreated controls. *P < 0.05 and **P < 0.01.
